These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 17162272)
1. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Cotiga D; Ehlert F; Sherrid M Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272 [TBL] [Abstract][Full Text] [Related]
3. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196 [TBL] [Abstract][Full Text] [Related]
4. Sudden death and hypertrophic cardiomyopathy: a review. Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263 [TBL] [Abstract][Full Text] [Related]
5. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy]. Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death. Ostman-Smith I Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015 [TBL] [Abstract][Full Text] [Related]
8. [Interventional treatment in hypertrophic cardiomyopathy]. Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy]. Sadoul N; de Chillou C; Aliot E; McKenna WJ Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160 [TBL] [Abstract][Full Text] [Related]
10. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ; Spirito P J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577 [TBL] [Abstract][Full Text] [Related]
11. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Maron BJ; Spirito P Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462 [TBL] [Abstract][Full Text] [Related]
12. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Williams L; Frenneaux M Europace; 2007 Sep; 9(9):817-22. PubMed ID: 17522079 [TBL] [Abstract][Full Text] [Related]
13. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance. Pokorski RJ J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692 [TBL] [Abstract][Full Text] [Related]
15. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy]. Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331 [TBL] [Abstract][Full Text] [Related]
16. ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362 [TBL] [Abstract][Full Text] [Related]
17. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596 [TBL] [Abstract][Full Text] [Related]
18. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy]. Maron BJ Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193 [No Abstract] [Full Text] [Related]
20. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy. Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]